BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16861916)

  • 1. Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers.
    Li QX; Zhao J; Liu JY; Jia LT; Huang HY; Xu YM; Zhang Y; Zhang R; Wang CJ; Yao LB; Chen SY; Yang AG
    Cancer Biol Ther; 2006 Jul; 5(7):860-6. PubMed ID: 16861916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic potential of survivin promoter-driven siRNA on suppressing tumor growth and enhancing radiosensitivity of human cervical carcinoma cells via downregulating hTERT gene expression.
    Wang R; Lin F; Wang X; Gao P; Dong K; Wei SH; Cheng SY; Zhang HZ
    Cancer Biol Ther; 2007 Aug; 6(8):1295-301. PubMed ID: 17712228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short hairpin RNA targeting survivin inhibits growth and angiogenesis of glioma U251 cells.
    Zhen HN; Li LW; Zhang W; Fei Z; Shi CH; Yang TT; Bai WT; Zhang X
    Int J Oncol; 2007 Nov; 31(5):1111-7. PubMed ID: 17912437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo.
    Ghadersohi A; Pan D; Fayazi Z; Hicks DG; Winston JS; Li F
    Breast Cancer Res Treat; 2007 Mar; 102(1):19-30. PubMed ID: 16897429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
    Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.
    Tu SP; Jiang XH; Lin MC; Cui JT; Yang Y; Lum CT; Zou B; Zhu YB; Jiang SH; Wong WM; Chan AO; Yuen MF; Lam SK; Kung HF; Wong BC
    Cancer Res; 2003 Nov; 63(22):7724-32. PubMed ID: 14633697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibiting survivin expression enhances TRAIL-induced tumoricidal activity in human hepatocellular carcinoma via cell cycle arrest.
    He SQ; Rehman H; Gong MG; Zhao YZ; Huang ZY; Li CH; Zhang WG; Chen XP
    Cancer Biol Ther; 2007 Aug; 6(8):1247-57. PubMed ID: 17700059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo.
    Uchida H; Tanaka T; Sasaki K; Kato K; Dehari H; Ito Y; Kobune M; Miyagishi M; Taira K; Tahara H; Hamada H
    Mol Ther; 2004 Jul; 10(1):162-71. PubMed ID: 15233951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo.
    Li Z; Yin PH; Yang SS; Li QY; Chang T; Fang L; Shi LX; Fang GE
    Mol Med Rep; 2013 Apr; 7(4):1215-22. PubMed ID: 23404494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing stathmin gene expression by survivin promoter-driven siRNA vector to reverse malignant phenotype of tumor cells.
    Zhang HZ; Wang Y; Gao P; Lin F; Liu L; Yu B; Ren JH; Zhao H; Wang R
    Cancer Biol Ther; 2006 Nov; 5(11):1457-61. PubMed ID: 17012855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-Independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by suppression of XIAP expression.
    Kim SH; Singh SV
    Cancer Prev Res (Phila); 2010 Jun; 3(6):718-26. PubMed ID: 20484174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
    Sun HB; Zheng HY; Yan X
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.
    Yang W; Sun T; Cao J; Liu F
    Int J Radiat Biol; 2010 Jun; 86(6):445-57. PubMed ID: 20470195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [siRNA against survivin coupling with epirubicin enhances to induce breast cancer cell MCF-7 to apoptosis].
    Guan HT; Xue XH; Wang XJ; Li A; Qin ZY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):221-5. PubMed ID: 16608080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of survivin small interfering RNA on biological behaviors of bladder cancer T24 cells].
    Wang XL; Hou JQ; Wen DG; He J
    Ai Zheng; 2008 Mar; 27(3):253-7. PubMed ID: 18334113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.
    George J; Banik NL; Ray SK
    Neuro Oncol; 2010 Nov; 12(11):1088-101. PubMed ID: 20679253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.